1. Wild S, Sicree R, Gojka R, et al. Global prevalence of diabetes: Estimates for the year 2000 and predictions for 2030. Diabetes Care 2004;27:1047-1053.
2. National Diabetes Fact Sheet. Center for Disease Control 2005.
3. American Diabetes Association. Standards of medical care in diabetes (Position statement). Diabetes Care 2005;28:S4-S36.
4. White P. Pregnancy complicating diabetes. Am J Med 1949;7:609.
5. American Diabetes Association. Gestational diabetes mellitus (Position statement). Diabetes Care 2004;27:S88-S90.
6. Green JR, Pawson IG, Schumacher LB, et al. Glucose intolerance in pregnancy: Ethnic variation and influence of body habitus. Am J Obstet Gynecol 1990;163:86.
7. King E. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 1998;21:B9-B13.
8. Bergqvist N. The gonadal function in female diabetics. Acta Endocrinol Copenh 1954;19:1.
9. Djursing H, Nyholm HC, Hagen C, et al. Clinical and hormonal characteristics in women with anovulation and insulin-treated diabetes mellitus. Am J Obstet Gynecol 1982;143:876.
10. Kjaer K, Hagen C, Sando SH, et al. Infertility and pregnancy outcome in an unselected group of women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol 1992;166:1412.
11. Briese V, Muller H. Diabetes mellitus: An epidemiologic study of fertility, contraception and sterility. Geburtshilfe Frauenheilkd 1995;55:270.
12. Kirchick HJ, Keyes PL, Frye BE. An explanation for anovulation in immature alloxan-diabetic rats treated with pregnant mare's serum gonadotropin: Reduced pituitary response to gonadotropin releasing hormone. Endocrinology 1979;105:1343.
13. Djursing H, Nyholm HC, Hagen C, et al. Depressed prolactin levels in diabetic women with anovulation. Acta Obstet Gynecol Scand 1982;61:403.
14. Valdes CT, Elkind-Hirsch KE, Rogers DG. Diabetes-induced alterations of reproductive and adrenal function in the female rat. Neuroendocrinology 1990;51:406.
15. Djursing H, Hagen C, Nyholm HC, et al. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus. J Clin Endocrinol Metab 1983;56:1016.
16. Liu TYF, Lin HS, Johnson DC. Serum FSH, LH, and the ovarian response to exogenous gonadotropins in alloxan diabetic immature female rats. Endocrinology 1972;91:1172.
17. Diamond MP, Lavy G, Polan ML. Progesterone production from granulosa cells of individual human follicles derived from diabetic and non-diabetic subjects. Int J Fertil 1989;34:204.
18. Nielsen G, Moller M, Sorensen H. HbA1 C in early diabetic pregnancy and pregnancy outcomes. Diabetes Care 2006;29:2612.
19. Miodovnik M, Skillman C, Holroyde JC, et al. Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion among insulin-dependent diabetic women. Am J Obstet Gynecol 1985;153:439.
20. Mills JL, Simpson JL, Driscoll SG, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988;319:1617.
21. Miodovnik M, Mimouni F, Tsang RC, et al. Glycemic control and spontaneous abortion in insulin-dependent diabetic women. Obstet Gynecol 1986;68:366.
22. Casson IF, Clarke CA, Howard CV, et al. Outcomes of pregnancy in insulin dependent diabetic women: Results of a five year population cohort study. BMJ 1997;31:275.
23. Lorenzen T, Pociot F, Johannesen J. A populations-based survey of frequencies of self-reported spontaneous and induced abortion is in Danish women with type 1 diabetes mellitus. Danish IDDM Epidemiology and Genetics Group. Diabet Med 1999;16:472.
24. Mills JL, Knopp RH, Simpson JL, et al. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 1988;318:671.
25. Greene MF, Hare JW, Cloherty JP, et al. First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 1989;39:225.
26. Wright AD, Nicholson HO, Pollock A, et al. Spontaneous abortion and diabetes mellitus. Postgrad Med J 1983;59:295.
27. Mills JL, Simpson JL, Driscoll SG, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988;319:1617.
28. Nielsen GL, Sorensen HT, Nielson PH, et al. Glycosylated hemoglobin as predictor of adverse fetal outcome in type 1 diabetic pregnancies. Acta Diabetol 1997;34:217.
29. Rosenn B, Miodovnik M, Combs CA, et al. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 1994;84: 515.
Mello G, Parretti E, Mecacci F, et al. Glycemic thresholds in spontaneous abortion during the first trimester in pregnant women with insulin dependent diabetes. Minerva Ginecol 1997;49:365. Hanson U, Persson B, Thunell S. Relationship between haemoglobin A1c in early Type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia 1990;33:100.
Torchinsky A, Toder V, Carp H, et al. In vivo evidence for the existence of a threshold for hyperglycemia-induced major fetal malformations: relevance to the etiology of diabetic terato-genesis. Early Pregnancy 1997;3:27.
Mimouni F, Tsang RC. Pregnancy outcome in insulin-dependent diabetes: Temporal relationships with metabolic control during specific pregnancy periods. Am J Perinatol 1988;5:334. Rosenn B, Miodovnik M, Combs CA, et al. Preconception management of insulin-dependent diabetes: Improvement of pregnancy outcome. Obstet Gynecol 1991;77:846. Rayburn W. Changes in insulin therapy during pregnancy. Am J Perinatol 1985;2:271. Weiss P, Hoffman H. Intensified conventional insulin therapy for the pregnant diabetic patient. Obstet Gynecol 1984;64:629.
Jovanovic L, Peterson M. Optimal insulin delivery for the pregnant diabetic patients. Diabetes Care 1982;5:24.
Langer O, Anyaegbunam A, Brustman L, et al. Gestational diabetes: Insulin requirements in pregnancy. Am J Obstet Gynecol 1987;157:669.
Bendon RW, Mimouni F, Khoury J. et al. Histopathology of spontaneous abortion in diabetic pregnancies. Am J Perinatol 1990;7:207.
Clinical Practice recommendations 2003: Diabetic Retinopathy Diabetes Care 2003;26(Suppl 1):S99.
The DCCT Research Group: Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology 1995;102:647. Alvarsson ML, Grill VE. Effect of long term glycemic control on the onset of retinopathy in IDDM subjects: A longitudinal and retrospective study. Diabetes Research 1989;10:75. Klein R, Klein BEK, Moss SE, et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988;260:2864.
Brinchmann-Hansen O, Dahl-Jorgensen K, Sandvik L, et al. Blood glucose concentrations and progression of diabetic retinopathy: The seven year results of the Oslo Study. BMJ 1992;304: 19.
American College of Obstetricians and Gynecologists. Diabetes and pregnancy. ACOG Technical Bulletin No. 200. American College of Obstetricians and Gynecologists, December 1994, Danvers, MA.
Alvarsson ML, Grill VE. Effect of long term glycemic control on the onset of retinopathy in IDDM subjects: A longitudinal and retrospective study. Diabetes Research 1989;10:75. Klein R, Klein BEK, Moss SE, et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988;260:2864.
Brinchmann-Hansen O, Dahl-Jorgensen K, Sandvik L, et al. Blood glucose concentrations and progression of diabetic retinopathy: The seven year results of the Oslo Study. BMJ 1992;304:19. Reichard P, Britz A, Carlsson P, et al. Metabolic control and complications over 3 years in patients with insulin dependent diabetes (IDDM): The Stockholm Diabetes Intervention Study (SDIS). J Intern Med 1990;228:511.
Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med 1984;311:365.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977.
Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, et al. Rapid tightening of blood glucose leads to transient deterioration of retinopathy in insulin-dependent diabetes mellitus: The Oslo Study. BMJ 1985;290:811.
54. Arner P, Sjoberg S, Gjotterberg M, et al. Circulating insulin-like growth factor I in type 1 (insulin-dependent) diabetic patients with retinopathy. Diabetologia 1989;32:753.
55. Hyer SL, Sharp PS, Sleightholm M, et al. Progression of diabetic retinopathy and changes in serum insulin-like growth factor I (IGFI) during continuous subcutaneous insulin infusion (CSII). Horm Metab Res 1989;21:18.
56. Hill CR, Kissun RD, Garner A. Angiogenic factor in vitreous from diabetic retinopathy. Expe-rientia 1983;39:583.
57. Castellon R, Hamdi HK, Sacerio I, et al. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp Eye Res 2002;74:523.
58. Presta M, Mignatti P, Mullins DE, et al. Human placental tissue stimulates bovine capillary endothelial cell growth, migration and protease production. Biosci Rep 1985;5:783.
59. Hill DJ, Flyvbjerg A, Arany E, et al. Increased levels of serum fibroblast growth factor-2 in diabetic pregnant women with retinopathy. J Clin Endocrinol Metab 1997;82:1452.
60. Cousins L. Pregnancy complications among diabetic women: Review 1965-1985. Obstet Gynecol Surv 1987;42:140.
61. Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: Association with hypertension in pregnancy. Am J Obstet Gynecol 1992;166:1214.
62. Lovestam-Adrian M, Agardh CD, Aberg A, et al. Preeclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in type 1 diabetic patients. Diabet Med 1997;14:1059.
63. Horvat M, Maclean H, Goldberg L, et al. Diabetic retinopathy in pregnancy: A 12-year prospective survey. Br J Ophthalmol 1980;64:398.
64. Moloney JBM, Drury MI. The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol 1982;93:745.
65. Dibble CM, Kochenour NK, Worley RJ, et al. Effect of pregnancy on diabetic retinopathy. Obstet Gynecol 1982;59:699.
66. Price JH, Hadden DR, Archer DB, et al. Diabetic retinopathy in pregnancy. Br J Obstet Gynaecol 1984;91:11.
67. Ohrt V. The influence of pregnancy on diabetic retinopathy with special regard to the reversible changes shown in 100 pregnancies. Acta Ophthalmol 1984;62:603.
68. Jovanovic R, Jovanovic L. Obstetric management when normoglycemia is maintained in diabetic pregnant women with vascular compromise. Am J Obstet Gynecol 1984;149:617.
69. Phelps RL, Sakol P, Metzger BE, et al. Changes in diabetic retinopathy during pregnancy. Arch Ophthalmol 1986;104:1806.
70. Serup L. Influence of pregnancy on diabetic retinopathy. Acta Endocrinol (Copenhagen) 1986;277(Suppl):122.
71. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy: The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care 1995;18:631.
72. Axer-Siegel R, Hod M, Fink-Cohen S, et al. Diabetic retinopathy during pregnancy. Ophthalmology 1996;103:1815.
73. Lapolla A, Cardone C, Negrin P, et al. Pregnancy does not induce or worsen retinal and peripheral nerve dysfunction in insulin-dependent diabetic women. J Diabetes Complications 1998;12:74.
74. Temple RC, Aldridge VA, Sampson MJ, et al. Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabet Med 2001;18:573.
75. Selby JV, FitzSimmons SC, Newman JM, et al. The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control. JAMA 1990;263:1954.
76. Reichard P, Britz A, Carlsson P, et al. Metabolic control and complications over 3 years in patients with insulin dependent diabetes (IDDM): The Stockholm Diabetes Intervention Study (SDIS). J Intern Med 1990;228:511.
77. The Diabetes Control and complications Trial Research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977.
78. McCance DR, Hadden DR. Atkinson AB, et al. The relationship between long-term glycemic control and diabetic nephropathy. QJM 1992;82:53.
79. Reichard P, Rosenqvist U. Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy. J Intern Med 1989;226:81.
80. Parving H-H. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 1991;14:260.
81. Jerums G, Allen TJ, Tsalamandris C, et al. The Melbourne Diabetic Nephropathy Study Group: Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. Kidney Int 1992;41:904.
82. Hostetter TH. Pathogenesis of diabetic glomerulopathy: Hemodynamic considerations. Semin Nephrol 1990;10:219.
83. Bank N. Mechanisms of diabetic hyperfiltration. Kidney Int 1991;40:792.
84. Zeller KR. Low-protein diets in renal disease. Diabetes Care 1991;14:856.
85. Dodds RA, Keen H. Low protein diet and conservation of renal function in diabetic nephropathy. Diabetes Metab 1990;16:464.
86. Hod M, van Dijk DJ, Karp M, et al. Diabetic nephropathy and pregnancy: The effect of ACE inhibitors prior to pregnancy and fetomaternal outcome. Nephrol Dial Transplant 1995;10:2328.
87. Carr D, Koontz GL, Gardella C, et al. Diabetic Nephropathy in Pregnancy: Suboptimal Hypertensive Control Associated With Preterm Delivery. Am J Hypertens 2006;19:513.
88. Mauer SM, Sutherland DER, Steffes MW. Relationship of systemic blood pressure to nephropathology in insulin-dependent diabetes mellitus. Kidney Int 1992;41:736.
89. Mogensen CE, Hansen KW, Osterby R, et al. Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care 1992;15:1192.
90. Parving H-H. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 1991;14:260.
91. Jerums G, Allen TJ, Tsalamandris C, et al. The Melbourne Diabetic Nephropathy Study Group: Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. Kidney Int 1992;41:904.
92. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congential malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443.
93. Reece EA, Coustan DR, Hayslett JP, et al. Diabetic nephropathy: Pregnancy performance and fetomaternal outcome. Am J Obstet Gynecol 1988;159:56.
94. Reece EA, Winn HN, Hayslett JP, et al. Does pregnancy alter the rate of progression of diabetic nephropathy? Am J Perinatol 1990;7:193.
95. Gordon M, Landon MB, Samuels P, et al. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol 1996;87:401.
96. Rosenn BM, Miodovnik M, Khoury JC, et al. Outcome of pregnancy in women with diabetic nephropathy. Am J Obstet Gynecol 1997;176:S179.
97. Dunne FP, Chowdhury TA, Hartland A, et al. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy. QJM 1999;92:451.
98. Khoury JC, Miodovnik M, LeMasters G, et al. Pregnancy outcome and progression of diabetic nephropathy. What's next? J Matern Fetal Neonatal Med 2002;11:238.
99. Bar J, Ben-Rafael Z, Padoa A, et al. Prediction of pregnancy outcome in subgroups of women with renal disease. Clinical Nephrology 2002;53:437.
100. Ekbom P, Damm P, Feldt-Rasmussen B., et al. Pregnancy Outcome in Type I diabetic Women with Microalbuminuria. Diabetes Care 2001;24:1739.
101. Kitzmiller JL, Brown ER, Phillippe M. et al. Diabetic nephropathy and perinatal outcome. Am J Obstet Gynecol 1981;141:741.
102. Grenfell A, Brudenell JM, Doddridge MC, et al. Pregnancy in diabetic women who have proteinuria. QJM 1986;59:379.
103. Kimmerle R, Zass RP, Cupisti S, et al. Pregnancies in women with diabetic nephropathy: Long-term outcome for mother and child. Diabetologia 1995;38:27.
104. Kalter H. Perinatal mortality and congenital malformations in infants born to women with insulin-dependent diabetes mellitus: United States, Canada and Europe, 1940-1988. Morb Mortal Wkly Rep 1990;39:363.
105. Kucera J. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 1971;7:61.
106. Becerra JE, Khoury MJ, Cordero JF, et al. Diabetes mellitus during pregnancy and the risks for specific birth defects: A populations-based case-control study. Pediatrics 1990;85:1.
107. Cousins L. Congenital anomalies among infants of diabetic mothers: Etiology, prevention, prenatal diagnosis. Am J Obstet Gynecol 1983;147:333.
108. Schaefer-Graf UM,Buchanan TA, Xiang A, et al. Patterns of congenital anomalies and relationship to initial internal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 2000;182:313.
109. Towner D, Kjos SL, Leung B, et al. Congenital Malformations in Pregnancies Complicated by NIDDM. Diabetes Care 1995;18:1446.
110. Rosenn BM, Miodovnik M, Khoury JC, et al. Pregnancy outcome in women with Type 2 diabetes mellitus. Am J Obstet Gynecol 1996;147:394.
111. Schaefer UM, Songster G, Xiang A., et al. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstet Gynecol 1997;177:1165.
112. Sheffield JS, Butler-Koster EL, Casey BM, et al. Maternal Diabetes Mellitus and Infant Malformations. Am J Obstet Gynecol 2002;100:925.
113. Casson IF, Clarke CA, Howard CV, et al. Outcomes of pregnancy in insulin dependent diabetic women: Results of a five year population cohort study. BMJ 1997;31:275.
114. Hawthorne G, Robson S, Ryall EA, et al. Prospective population bases survey of outcome of pregnancy in diabetic women: Results of the Northern Diabetic Pregnancy Audit, 1994. BMJ 1997;315:279.
115. Nordstrom L, Spetz E, Wallstrom K, et al. Metabolic control and pregnancy outcome among women with insulin-dependent diabetes mellitus: A twelve-year follow-up in the country of Jamtland, Sweden. Acta Obstet Gynecol Scand 1998;77:284.
116. The DCCT Research Group. Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol 1996;174:1343.
117. Elixhauser A, Weschler JM, Kitzmiller JL, et al. Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care 1993;16:1146.
118. Herman WH, Janz NK, Becker MP, et al. Diabetes and pregnancy: Preconception care, pregnancy outcomes, resource utlization and costs. J Reprod Med 1999;44:33.
119. Moore TR. Diabetes in pregnancy. In: Creasy RK, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice, 4th edn. Philadelphia: WB Saunders, 1999:967.
120. Siddiqi TA, Miodovnik M, Mimouni F, et al. Biphasic fetal intrauterine growth in insulin-dependent diabetic pregnancies. J Am Coll Nutr 1989;8:225.
121. Eriksson UJ, Lewis NJ, Freinkel N. Growth retardation during early organogenesis in embryos of experimental diabetic rats. Diabetes 1984;33:281.
122. Pedersen JF, Molsted-Pedersen L. Early growth retardation in diabetic pregnancy. BMJ 1979;1:18.
123. Ogata ES, Sabbagha R, Metzger BE, et al. Serial ultrasonography to assess evolving fetal macrosomia: Studies in 23 pregnant diabetic women. JAMA 1980;243:2405.
124. Tsang RC, Ballard JL, Braun C. The infant of the diabetic mother: Today and tomorrow. Clin Obstet Gynecol 1981;24:125.
125. Cousins L. Pregnancy complications among diabetic women: Review 1965-1985. Obstet Gynecol Surv 1987;43:10.
126. Langer O, ed. The Diabetes in Pregnancy Dilemma, 1st edn. Lanham: University Press of America, 2006.
Was this article helpful?